Associated Papers
Genetic Variation in NFKB1 and NFKBIA and Susceptibility to Coronary Artery Disease in a Chinese Uygur Population.
Lai HM et al.
Plos One, 2015
Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis.
Balood M et al.
Molecular Biology Reports, 2014
The role of NF-κB1A promoter polymorphisms on coronary artery disease risk.
Özbilüm N et al.
Basic & Clinical Pharmacology & Toxicology, 2013
Effects of NFKB1 and NFKBIA gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathological features.
Cheng CW et al.
Plos One, 2013
Association of the NFKBIA gene polymorphisms with susceptibility to autoimmune and inflammatory diseases: a meta-analysis.
Zhang GL et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.], 2011
IkappaBalpha promoter polymorphisms in patients with primary Sjögren's syndrome.
Ou TT et al.
Journal of Clinical Immunology, 2008
IkappaBalpha promoter polymorphisms in patients with rheumatoid arthritis.
Lin CH et al.
International Journal of Immunogenetics, 2007
Select a paper to view details